Drug Development

Pfizer's CD22-targeted cancer drug inotuzumab wins an accelerated OK at FDA

Results, Research Institutes

With CAR-T marketing looming, early study highlights potential of TCR engineering

New Products

Watch out Tesaro, AstraZeneca and Merck get FDA OK for broad use of Lynparza
More news caret

calendar Protocols

Quick hits from around the biopharma web

Aug 18

Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study

Aug 17

BlueRock expands Toronto ops; Unity brings B round to $151M; Novartis backs Altimmune's $15M raise

Aug 16

Takeda inks discovery pact with Stanford; Jounce taps Ariad vet Cole as new CBO

Aug 15

Biosims making slow progress battling blockbusters for market share; FibroGen raising $300M

More Protocols caret

thumbthumb Thumbs Up/Down

Jun 16

From bombs to bromides? Trump’s jousting with biopharma may well boil down to a handshake on drug prices

Jun 9

8 stars: A look back at ASCO spotlights the top cancer drugs to watch, and 1 to forget

Jun 2

Thumbs up: Cancer drug R&D is exploding, get ready for the pricing debate to follow

May 26

Some worthy initiatives out of the FDA fall far short of an effective federal plan to rein in drug prices

More Thumbs Up/Downcaret

DNA Deep dives

Optimizing clinical outcomes for challenging molecules with lipid-based drug delivery

What’s a biotech CEO worth? The top 15 pay packages puts a spotlight on performance — usually

A biotech billionaire tops the list of the 15 highest paid R&D execs in biopharma

The top 15 spenders in the global drug R&D business: 2017

Planning a clinical supply program? Don’t overlook primary packaging.

Alzheimer’s: Learning From a Legacy of Bitter Setbacks

twitter Marco

Hot BioTwitter bot - last updated ago

arrow-thick Most Viral

How HIV Became a Cancer Cure

WSJ a day

Here's the visual proof of why vaccines do more good than harm

Science | AAAS a day

Preemptive shaming assault on Novartis' CAR-T pioneer underscores a disconnect on R&D costs

ENDPOINTS NEWS John Carroll a day

With CAR-T marketing looming, early study highlights potential of TCR engineering

ENDPOINTS NEWS John Carroll a day

23andMe Condemns "All Forms Of Racism." But White Supremacists Can Still Use Its Site.

BuzzFeed a day

Scientists, Out $12 Million, Sue Delaware Over Seizure of Their Stock

WSJ a day

Global Biotech M&A Takes a Breather on Looming Tax Reform

Bloomberg Bailey Lipschultz a day

Cellectis' UCART123 Administered to First Patient with BPDCN in Phase I Clinical Trial at MD Anderson Cancer Center | Cellectis

Cellectis a day

Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers

FiercePharma Eric Sagonowsky a day

A Speedier Way to Catalog Human Cells (All 37 Trillion of Them)

New York Times Carl Zimmer a day

timer Latest

JAMA

Conversion to Parkinson Disease in the PARS Prodromal Cohort

WSJ

How HIV Became a Cancer Cure

SHU

NLRP3 and STING enhance immune attack on cancer

BioWorld

Trump signs FDA user fee bill, staving off agency layoffs

BioCentury

Advocacy group meeting with Novartis to discuss price for CAR T

paper.li

The Stem Cell Transplant Daily

Linkedin

A Courageous Leader Triggers a Moral Revolt Among CEOs

LWW

The Vital Need for Adequate Insurance for Cancer Patients : Oncology Times

ENDPOINTS NEWS

Thomas Wynn makes the leap out of the NIH and into a lead discovery post for Pfizer

Science | AAAS

Here's the visual proof of why vaccines do more good than harm

fire Hot This Week

1

Twitter

Donald J. Trump on Twitter: Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES!

2

STAT

On Ken Frazier's decision: A pharma exec shows moral leadership

3

Forbes

What You Should Know About Ken Frazier, The CEO Who Just Resigned From A Trump Advisory Council

4

Harper's magazine

Public Enemy

5

STAT

Merck CEO quits Trump panel in 'stand against violence and extremism'

6

WSJ

How HIV Became a Cancer Cure

7

WSJ

Why Merck's Pricing Candor is Good for Big Pharma

8

Twitter

Donald J. Trump on Twitter: @Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!

9

Science | AAAS

Here's the visual proof of why vaccines do more good than harm

10

New York Times

A Cancer Conundrum: Too Many Drug Trials, Too Few Patients

Follow Marco caret

Contact Endpoints News

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back
Thank you for staying with us. It's great to have you on board!
Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?
← Go back

Sign-in with a magic link

One-time use, expires in minutes.